Main Session
Sep
29
SS 27 - Advances in Multimodal Therapy for Glioblastoma: From Phase I to Phase III Trials
242 - Intratumoral Heterogeneity of Mutational Drivers Associated with Radiation Response in Glioblastoma
Presenter(s)
Taylor Weiskittel, MD, PhD, MS - Mayo Clinic, Scottsdale, AZ